Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics

Validated preclinical studies have provided evidence that anti-vascular endothelial growth factor (VEGF) compounds enhance the activity of subsequent antitumor therapy, but the mechanism of this potentiation is far from clear. The most widespread explanation is enhanced delivery of therapeutics due...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuso Nerini, Ilaria, Cesca, Marta, Bizzaro, Francesca, Giavazzi, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928348/
https://www.ncbi.nlm.nih.gov/pubmed/27357621
http://dx.doi.org/10.1186/s40880-016-0123-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928348/
https://www.ncbi.nlm.nih.gov/pubmed/27357621
http://dx.doi.org/10.1186/s40880-016-0123-1

Ejemplares similares